Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy

Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy

Objective: Botulinum toxin (BoNT-A) is widely used in combined treatment for spastic cerebral palsy, but its added value preceding comprehensive rehabilitation for motor impairments, gait, and goal attainment has not been studied. Design: A comparative multi-centre trial, in which two groups underwe...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabienne Schasfoort (Author), Robert Pangalila (Author), Emiel M. Sneekes (Author), Coriene Catsman (Author), Jules Becher (Author), Herwin Horemans (Author), Henk J. Stam (Author), Annet J. Dallmeijer (Author), Johannes B.J Bussmann (Author)
Format: Book
Published: Medical Journals Sweden, 2018-07-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items